Die Suchmaschine für Unternehmensdaten in Europa
EU-Förderung (3.939.918 €): Photonik für das Gesundheitswesen: multiscAle Krebsdiagnose und Therapie Hor03.07.2020 EU-Rahmenprogramm für Forschung und Innovation "Horizont"
Auf einen Blick
Text
Photonik für das Gesundheitswesen: multiscAle Krebsdiagnose und Therapie
The European Training Network PHAST (Photonics for Healthcare: multiscAle cancer diagnosiS and Therapy) provides excellent, highly-skilled education and training in the vibrant field of Biophotonics for 15 Early Stage Researchers (ESRs) in a strong multidisciplinary PhD programme. PHAST addresses some relevant “unmet needs” of the medical community in prevention, diagnosis and treatment of cancer – one of the leading causes of death worldwide – to significantly improve the quality of life for European society. The main scientific goal of PHAST is to develop multiscale advanced photonic technologies for the diagnosis of cancer in vitro and in vivo and the monitoring of therapy for personalized medicine, through its four specific objectives: 1. In-vitro diagnosis as point-of-care approach through optical spectroscopy combined with innovative sampling techniques. 2. Tissue diagnostics and functional monitoring by optical fibre-based biopsy and diffuse optical spectroscopy. 3. Microscale cancer monitoring by multimodal optical imaging of tumour borders during surgery. 4. Macroscale therapy monitoring by diffuse optical spectroscopy, multifunctional optical fibre sensors, autofluorescence, and hyperspectral imaging. The multi-scale level approach employed by PHAST will allow early cancer detection from molecular disease markers in body-liquids up to live organs. In specific cases these techniques will be validated in the clinic thanks to close collaboration with medical institutions. The ESRs will be trained to all the technologies through hands-on laboratory platforms, thematic workshops and courses to build solid careers as biophotonics professionals in both academic and non-academic sectors. This will be possible thanks to the multidisciplinary environment created by the PHAST consortium, composed of research institutions, 2 hospitals and 8 industries, among them specialized small companies as well as global players in the field such as Horiba, Philips and Zeiss.
Geförderte Unternehmen:
| Firmenname | Förderungssumme |
| Albert-Ludwigs-Universitaet Freiburg | 252.788 € |
| Fondazione Links - Leading Innovation & Knowledge FOR Society | 261.500 € |
| Friedrich-Schiller-Universität Jena | 252.788 € |
| Fundacio Institut de Ciencies Fotoniques | 250.905 € |
| Grintech GmbH | 252.788 € |
| Horiba France SAS | 274.802 € |
| Leibniz-Institut Fuer Photonische Technologien e. V. | 252.788 € |
| Medizinische Universitaet Wien | 264.207 € |
| Ospedale SAN Raffaele Srl | 261.500 € |
| Politecnico Di Milano | 261.500 € |
| Politecnico Di Torino | 261.500 € |
| Spectracure AB | 281.983 € |
| Universita Degli Studi Di Parma | 261.500 € |
| University College Cork - National University of Ireland, Cork | 549.369 € |
Quelle: https://cordis.europa.eu/project/id/860185
Diese Bekanntmachung wurde von Englisch nach Deutsch übersetzt. Die Bekanntmachung bezieht sich auf einen vergangenen Zeitpunkt, und spiegelt nicht notwendigerweise den heutigen Stand wider.
